OBJECTIVES: Pain control after thoracotomy is an important issue that affects the outcome in thoracic surgery. Intercostal nerve preservation (ICNP) has increased interest in the outcomes of conventional thoracotomy. The current study critically evaluates the role of preservation of the intercostal nerve in early and late pain control and its benefit in patients undergoing thoracotomy.
INTRODUCTION
It is mandatory to perform thoracotomy in most patients suffering from lung cancer or other intrathoracic diseases. However, thoracotomy is associated with considerable pain and morbidity. Unfortunately, it is one of the most painful surgical incisions currently used. The main source of pain after thoracotomy is probably from injury to the intercostal nerve [1] . During thoracotomy, the intercostal nerve is routinely damaged [2] either during performing the incision, through compression of the retractor, or sometimes during closure of the thoracotomy. Neural pain is one of the most persistent severe pains [3, 4] . Failure to inspire deeply before a forceful exhalation results in an ineffective cough, which in turn promotes retention of secretion, leading to airway closure and atelectasis. Thus, patients with limited lung functions are usually candidates for reintubation [5] . Therefore, pain control after thoracotomy is an important issue to avoid serious postoperative complications [6] . Providing good pain control after thoracotomy would not only help to avoid many postoperative complications, but also better control the chronic postthoracotomy pain (CPTP). Chronic post-thoracotomy pain syndrome (CPTPS) is a continuous dysaesthetic burning and aching in the general area of the incision that persists at least 2 months after thoracotomy and can occur in about 60% of patients. Again, the most likely cause of CPTPS is intercostal nerve damage [3, 7] . The first reference to CPTPS was in 1944 by US Army surgeons who noted chronic intercostal pain in men who had had a thoracotomy for chest trauma during the Second World War [8] . From their neurological examinations, they concluded that intercostal nerve damage was responsible and that there was no satisfactory treatment of damaged intercostal nerves and thus CPTP. They recommended careful handling of the nerves and avoidance of any operative technique that would result in unnecessary injury. Multiple incisions and approaches, as well as various methods for pain management, have been tried, with varied success [9, 10] . Harvesting an intercostal muscle flap to protect the nerve from damage was reported to be effective for pain control after thoracotomy [11, 12] . The goal of the present study was to analyse whether the intercostal nerve preservation (ICNP) without intercostal muscle flap is associated with reasonable pain control, including the experience of chronic pain.
PATIENTS AND METHODS

Study design
The inclusion criteria for the study were all patients undergoing thoracotomy between January 2006 and December 2010 at the Division of General Thoracic Surgery, who performed reliable visual analogue scale (VAS) for pain. All patients underwent thoracotomy through the same surgeon or under his supervision. Clinical records of all patients were prospectively collected using a standardized data set and definitions. A database containing detailed information on preoperative risk factors, diagnosis, operative details, pain management, postoperative course, morbidity and mortality outcomes was constructed. For the purpose of this study, patients were divided into two groups; Group I included patients with ICNP and Group II included patients with intercostal nerve sacrifice (ICNS). The data of both groups were retrospectively analysed. Preoperative characteristics, postoperative outcome, pain score, methods of pain control and rate of chronic pain were compared in both groups.
Reasons for intercostal nerve sacrifice
Since a few years previously, we have adopted ICNP during performing a thoracotomy in all patients. This was not possible in a subgroup of patients due to one or more of the following reasons: (i) massive pleural adhesions, (ii) outstanding pleuritis making identification of the nerve impossible, (iii) intercostals artery bleeding, (iv) stage III pleural empyema, (v) tumour infiltration of the thoracic wall or (vi) during extrapleural pneumonectomy.
Exclusion criteria
The following patients were excluded from the study: (i) all patients with thoracoscopic surgery, (ii) median sternotomy, (iii) emergency thoracotomy, (iv) rethoracotomy, (v) long stay at the intensive care unit (ICU), (vi) patients with preoperative thoracic pain, (vii) patients with unreliable VAS and (viii) patients who are lost to the follow-up.
Surgical techniques
Thoracotomy. After a double lumen tracheal intubation, the patient was placed in a standard lateral position, and the arm on the operated side was positioned above the head (90°flexion at the shoulder and the elbow joints). The usual thoracotomy incision was deepened in the subcutaneous fat and the lowest fibres of the pectoralis major muscle were divided. The fibres the of the serratus anterior muscle were divided backwards along its direction. The periosteum over the lower edge of the fifth rib was opened using a cautery. The periosteum was pulled down on the lower edge of the rib to protect the nerve (Fig. 1 ). The chest was entered under the lower edge of the rib. Through direct visualization of the nerve, this technique ensures the preservation of the nerve and the vessels (Fig. 1) . A thick pad of towels was used to protect the intercostal compartment from direct retractor compression. In some patients, the cartilage of the rib was divided 2 cm away from the sterno-costal joint, to insure better exposure.
Closure of thoracotomy. Two 24F and 28F soft chest tubes were placed through a separate small incision in the sixth intercostal space. Closure of the thoracotomy was done by light adaptation of the divided periosteum and intercostal muscles to the above related rib going over the upper edge of both corresponding ribs using PDS II ® loop. Muscular, subcutaneous and skin closure were done as usual.
Pain control
All our patients were considered candidates for thoracic epidural analgesia (TEA) except those with signs of active infection. Pain control through TEA was achieved through a standard protocol using Sufentanil (Sufenta epidural ® 5 µg/ml injection solution, JANSSEN-CILAG GmbH, Neuss, Germany) in combination with Bupivacain local anaesthetic (Carbostesin ® , 0.5%/ml, AstraZeneca, Germany). In addition, 1 g Metamizol-Natrium 1H 2 O (Novalgine ® Sanofi-Aventis Deutschland GmbH, Frankfurt, Germany) with normal saline solution (NaCl 0.9%) was given 3-4 times intravenously over the first 48 h postoperatively. Epidural catheters were removed between the third and the fourth postoperative day in all patients. Patients who did not receive TEA were managed either using patient controlled analgesia or Oxycodon 10 mg tablets (Oxygesic ® Mundipharma, Limburg, Germany) combined with non-steroidal anti inflammatory drugs (NSAID). All patients were provided with VAS to record their pain score on a chart from 0 to 10 (0 = no pain, 10 = unbearable pain).
Statistical analysis
SPSS for Windows was used for statistical analysis (SPSS 8.0 for Windows, SPSS Inc., Chicago, IL, USA). Univariate analysis was performed using the χ 2 test for qualitative, and the Mann-Whitney U-test for quantitative, data. Variables considered significant at the level of a P-value <0.01 on univariate analysis were subjected to multivariate, forwards, stepwise, binary, logistic regression analysis to detect their weight as predictors. Statistical significance was defined by P-value <0.05. Odds ratios (ORs) and their 95% confidence intervals (CIs) were added to provide an additional measure of statistical significance. Nagelkerke's pseudo R 2 values were used to provide an approximation of the goodness-of-fit of the logistic models. Intercorrelations were calculated to be able to rule out the possibility of multicollinearity between the various pain variables. Correlations were modest, ranging from 0.05 to 0.34, signalling that multicollinearity was not a problem. Analyses were done separately for women and men, as well as for patients from different geographical origins. Results of Caucasian males would dominate those of Asian females due to their high proportion in the data.
Results
Patient data
Between January 2006 and December 2010, 491 patients underwent thoracotomy at our institution through the same surgeon or under his supervision. Eighty-one patients were excluded from the study due to incomplete data. Patient characteristics are summarized in Table 1 . Group I consisted of 288 patients [206 male (71%), P < 0.001, mean age 66 years] who received thoracotomy with ICNP. Group II consisted of 122 patients [79 male (64%), P = 0.001, mean age 69 years] who underwent thoracotomy with ICNS. The procedures done were comparable in both groups (Table 2 ). Preoperative TEA was performed in 241 patients (83%) in Group I and in 94 patients (77%) in Group II.
Operative procedures
The operative procedures in all patients are summarized in Table 2 . All operative procedures in both groups were performed either with the same surgeon (n = 310) or under his supervision (n = 100). There was no significant difference in the operation time in both groups (136 min in Group I vs 144 min in Group II).
Statistical difference
Perioperative events are summarized in Table 3 . There was less use of opiate in Group I (P = 0.019) (Fig. 2) . Similarly, there were less doses of non-steroidal anti inflammatory drugs (NSAID) used in Group I, but it showed no statistical significance (P = 0.061). The visual analogue score was significantly higher in Group II patients (P = 0.002; Fig. 3 ). Early mobilization of the patients was significantly better in Group I (P = 0.031). There was less atelectasis in Group I (P = 0.002). The rate of pneumonia and re-admission to the ICU was higher in Group II (P = 0.017 and 0.023, respectively). The mean hospital stay was longer in Group Chronic obstructive lung diseases n = 70 n = 38 Arterial hypertension n = 33 n = 25 Atrial fibrillation n = 19 n = 6 Coronary heart diseases n = 13 n = 5 Myocardial infarction n = 5 n = 2 Diabetes mellitus n = 6 n = 9 Chronic renal failure n = 10 n = 4 Gastrointestinal ulcer n = 3 n = 2 Gastrointestinal tumour n = 4 n = 3 II (11 days) than in Group I (8 days) (P = 0.037). The rate of painfree patients at the time of hospital discharge was significantly higher in Group I (P = 0.028). An follow-up 2 weeks after hospital discharge showed more thoracic wall hypoesthesia in Group II (P = 0.034). Significant patient contentment in Group I was noticed (P = 0.014). Three-and 6-month postoperative followups showed less post-thoracotomy pain syndrome (PTPS) in Group I (P = 0.016; Fig. 4 ). There was no statistical difference related co-morbidity as well as all of the following factors: (i) anterolateral compared with lateral thoracotomy OR of 0.43 (95% CI 0.11-0.72); (ii) diagnosis with OR of 0.22 (95% CI 0.14-0.42); (iii) sex or social status OR of 0.38 (95% CI 0.21-0.63); (iv) race OR of 0.86 (95% CI 0.19-0.92).
DISCUSSION
Pain after thoracotomy can be very intense and can lead to severe postoperative cardio-pulmonary complications, particularly in patients with limited lung functions [13] . Several methods of pain management are currently employed to provide relief of post-thoracotomy pain. Each of the methods, however, is associated with specific problems and side effects [14] . According to anatomical and physiological considerations, intercostal nerve damage seems to be the most important factor in PTPSs [4] . The single best approach to chronic pain is to prevent it. This can be achieved by avoiding intercostal nerve damage and achieving optimal postoperative pain control [15] . In contrast to the technique described by Cerfolio et al. [11] , we noticed less pain in the group of patients who underwent preservation of the intercostals nerve without harvesting an intercostals muscle flap.
Although harvesting an intercostals muscle flap is easy, it is timeconsuming, and we do not always see an indication for the flap to be done. The same authors reported later, in 2008 [12] , their experience with harvesting the intercostals muscle flap, but without distal division, and they showed a better pain control in that group. Our technique is much simpler where the intercostals muscles are released only from the lower edge of the rib and then protected with a thick pad of towels prior to the application of the retractor. The author did not report the effect of their technique on CPTP, which is an important issue. Our results suggested that this method is effective in pain control, particularly CPTP. Conventional analgesia with intravenous administration of opiate with or without NSAID often does not result in satisfactory pain relief [6, 16] , and as per definition, it has no effect on CPTPS. Regional analgesia such as TEA is preferred over systemic analgesics. Although it is effective when correctly placed, is an invasive, time-consuming method. Moreover, it is not suitable for all patients and carries potential risks and limitations such as dural perforation, bleeding, infection, hypotension and bradycardia, as well as urinary retention and motor loss [17, 18] . TEA has no or less effect on controlling CPTP. Cryoanalgesia was reported to be effective on PTPC but it is associated with local atrophy of the muscle and sometimes changes of the skin sensation [14, 19] . Intercostal nerve blocks are time-consuming and often require repeated blocks. They also carry the risk of inducing pneumothorax and local anaesthetic toxicity [20] . Continuous intrapleural or intercostal local anaesthetics infusion, although avoiding the need for repeated blocks, increase the risk of toxicity [11] . Pain relief through nerve section and phenol ablation is no longer recommended due to the incidence of neuroma formation and permanent damage to the nerves with the consequence of muscle atrophy [21] . PTPS is often more difficult to manage than acute postoperative pain [14, 22] . There are many patients suffering from severe to moderate pain over a long period of time after thoracotomy, although they receive a combined analgesic and anti-epileptic drugs. For example, the incidence of long-term post-thoracotomy pain has been reported to be 80% at 3 months, 75% at 6 months and 61% at 1 year after surgery; the incidence of severe pain is 3-5% of patients [23, 24] . It has been demonstrated that posterolateral thoracotomy is behind the anterolateral thoracotomy or thoracoscopic surgery in terms of postoperative pulmonary function and walking capacity [25] . This is our experience also. Therefore, we usually perform muscle-sparing anterolateral or lateral thoracotomy whenever possible. ICNP is not an alternative method to aggressive perioperative pain management through an interdisciplinary approach, but it is an easy, feasible method, without side effects, to help control not only acute pain, but most important, to reduce the rate of CPTPS. Prospective randomized studies are needed to confirm these results.
LIMITATIONS
Although a prospective data collection was done, this study was conducted by a retrospective method of analysis, and due to the differences in the number of patients between both groups, some assumption of this work may be affected by a selection bias. The records of the patients with concomitant diseases were analysed, which showed in some cases no specifications for the degree or stage of that disease, for example CHD, COPD and emphysema. Therefore, the results in this study need to be supported with prospective randomized studies.
